|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/437 | (2006.01) |
| A61K 31/437 | (2013.01) | ||
| A61K 31/424 | (2006.01) | ||
| A61P 27/16 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/5513 | (2013.01) |
| (11) | Number of the document | 3576738 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18747812.8 |
| Date of filing the European patent application | 2018-02-02 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/016602 |
| Date | 2018-02-02 |
| (87) | Number | WO 2018/144827 |
| Date | 2018-08-09 |
| (30) | Number | Date | Country code |
| 201762530528 P | 2017-07-10 | US | |
| 201762454280 P | 2017-02-03 | US | |
| 201762536669 P | 2017-07-25 | US |
| (72) |
DURING, Matthew , US
|
| (73) |
Ovid Therapeutics, Inc. ,
441 Ninth Avenue, New York, NY 10001,
US
|
| (54) | GABOXADOL MONOHYDRATE IN THE TREATMENT OF TINNITUS |
| GABOXADOL MONOHYDRATE IN THE TREATMENT OF TINNITUS |